Daclatasvir

Category: Hepatitis



Daclatasvir Overview

Daclatasvir, sold under the trade name Daklinza, is a medication used in combination with other medications to treat hepatitis C (HCV).[1] The other medications used in combination include sofosbuvir, ribavirin, and interferon, vary depending on the virus type and whether the person has cirrhosis.[3] In significant difference to previous HCV therapies, Daclatasvir has the advantage of being taken orally in low application rates of normally 60 mg once daily with...

Read more Daclatasvir Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Daclatasvir

Recent Daclatasvir Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Daclatasvir
  • Tablet: 30mg, 60mg, 90mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Daclatasvir: (2 results)

Sorted by National Drug Code
  • 0087-0213 DACLATASVIR DIHYDROCHLORIDE 30 mg by Bristol-myers Squibb Company
  • 0087-0215 DACLATASVIR DIHYDROCHLORIDE 60 mg by Bristol-myers Squibb Company

Other drugs which contain Daclatasvir or a similar ingredient: (1 result)